zolpidem has been researched along with Neurotic Disorders in 1 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "3 years) diagnosed as having nonorganic insomnia (ICD-10: F 51." | 2.69 | Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder. ( Anderer, P; Brandstätter, N; Dantendorfer, K; Gruber, G; Mandl, M; Ritter, K; Saletu, B; Saletu-Zyhlarz, G; Zoghlami, A, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saletu-Zyhlarz, G | 1 |
| Anderer, P | 1 |
| Brandstätter, N | 1 |
| Dantendorfer, K | 1 |
| Gruber, G | 1 |
| Mandl, M | 1 |
| Ritter, K | 1 |
| Zoghlami, A | 1 |
| Saletu, B | 1 |
1 trial available for zolpidem and Neurotic Disorders
| Article | Year |
|---|---|
Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
Topics: Cross-Over Studies; Electroencephalography; Female; Health Status; Humans; Male; Middle Aged; Moveme | 2000 |